Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuhiro Ishida

Showing results (11-20 of 233) with videos related to

Pageof 24
Sort By:
Biological & Pharmaceutical Bulletin|April 4, 2022
Importance of Process Parameters Influencing the Mean Diameters of siRNA-Containing Lipid Nanoparticles (LNPs) on the in Vitro Activity of Prepared LNPsKazuya Nakamura, Keisuke Aihara, Tatsuhiro Ishida
Cancer Letters|November 14, 2016
Metronomic chemotherapy and nanocarrier platformsAmr S Abu Lila, Tatsuhiro Ishida
Biological & Pharmaceutical Bulletin|March 2, 2006
Safe and efficient drug delivery system with liposomes for intrathecal application of an antivasospastic drug, fasudilTatsuhiro Ishida, Yoshihiro Takanashi, Hiroshi Kiwada
Bioscience Reports|November 14, 2002
Liposome clearanceTatsuhiro Ishida, Hideyoshi Harashima, Hiroshi Kiwada
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 4, 2020
[Induction of Anti-PEG Immune Responses by PEGylation of Proteins]Taro Shimizu, Yu Ishima, Tatsuhiro Ishida
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 28, 2007
The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in ratsTatsuhiro Ishida, Syuntaro Kashima, Hiroshi Kiwada
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 3, 2007
Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomesXinYu Wang, Tatsuhiro Ishida, Hiroshi Kiwada
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 20, 2008
Synergistic antitumor activity of metronomic dosing of cyclophosphamide in combination with doxorubicin-containing PEGylated liposomes in a murine solid tumor modelTatsuhiro Ishida, Emi Shiraga, Hiroshi Kiwada
Biological & Pharmaceutical Bulletin|January 5, 2017
Liposomal Delivery Systems: Design Optimization and Current ApplicationsAmr Selim Abu Lila, Tatsuhiro Ishida
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 7, 2016
Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquidYasushi Miwa, Hidetoshi Hamamoto, Tatsuhiro Ishida
Pageof 24

Showing results (11-20 of 233) with videos related to

Sort By:
Pageof 24
Biological & Pharmaceutical Bulletin|April 4, 2022
Importance of Process Parameters Influencing the Mean Diameters of siRNA-Containing Lipid Nanoparticles (LNPs) on the in Vitro Activity of Prepared LNPsKazuya Nakamura, Keisuke Aihara, Tatsuhiro Ishida
Cancer Letters|November 14, 2016
Metronomic chemotherapy and nanocarrier platformsAmr S Abu Lila, Tatsuhiro Ishida
Biological & Pharmaceutical Bulletin|March 2, 2006
Safe and efficient drug delivery system with liposomes for intrathecal application of an antivasospastic drug, fasudilTatsuhiro Ishida, Yoshihiro Takanashi, Hiroshi Kiwada
Bioscience Reports|November 14, 2002
Liposome clearanceTatsuhiro Ishida, Hideyoshi Harashima, Hiroshi Kiwada
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|February 4, 2020
[Induction of Anti-PEG Immune Responses by PEGylation of Proteins]Taro Shimizu, Yu Ishima, Tatsuhiro Ishida
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 28, 2007
The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in ratsTatsuhiro Ishida, Syuntaro Kashima, Hiroshi Kiwada
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 3, 2007
Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomesXinYu Wang, Tatsuhiro Ishida, Hiroshi Kiwada
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 20, 2008
Synergistic antitumor activity of metronomic dosing of cyclophosphamide in combination with doxorubicin-containing PEGylated liposomes in a murine solid tumor modelTatsuhiro Ishida, Emi Shiraga, Hiroshi Kiwada
Biological & Pharmaceutical Bulletin|January 5, 2017
Liposomal Delivery Systems: Design Optimization and Current ApplicationsAmr Selim Abu Lila, Tatsuhiro Ishida
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 7, 2016
Lidocaine self-sacrificially improves the skin permeation of the acidic and poorly water-soluble drug etodolac via its transformation into an ionic liquidYasushi Miwa, Hidetoshi Hamamoto, Tatsuhiro Ishida
Pageof 24